Table 3 Associations between ESRD and prostate cancer, by stage at cancer diagnosis and PSA screening
Prostate cancer outcome | Number of cases | Association with ESRD, odds ratio (95% CI) | ||
|---|---|---|---|---|
Overall | PSA in 1 year before diagnosis/selection | No PSA in 1 year before diagnosis/selection | ||
All cancers | 193,632 | 0.42 (0.35, 0.50) | 0.52 (0.39, 0.71) | 0.52 (0.42, 0.66) |
By stage | ||||
Localized/regional | 136,904 | 0.34 (0.28, 0.41) | 0.45 (0.33, 0.62) | 0.42 (0.31, 0.55) |
Distant/metastic | 8,333 | 0.89 (0.62, 1.26) | 0.98 (0.54, 1.79) | 0.95 (0.61, 1.48) |
Unstaged | 8,302 | 0.84 (0.58, 1.22) | 1.12 (0.66, 1.89) | 0.91 (0.50, 1.66) |